This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Hanesbrands' (HBI) Q2 Earnings & Sales Surpass Estimates
by Zacks Equity Research
Hanesbrands' (HBI) second-quarter 2020 results benefit from robust base-case scenario for the apparel business and latest protective garment business.
Steven Madden's (SHOO) Loss Narrower, Revenues Miss in Q2
by Zacks Equity Research
Steven Madden (SHOO) posts narrower-than-expected loss in second-quarter 2020. However, revenues lagged the estimates, and both top and bottom lines fell year over year.
Carter's (CRI) Earnings & Sales Surpass Estimates in Q2
by Zacks Equity Research
Carter's (CRI) solid Q2 results gain from strong demand in stores that reopened recently and robust e-commerce growth.
Factors Likely to Influence Carter's (CRI) in Q2 Earnings
by Zacks Equity Research
Supply-chain disruptions stemming from COVID-19 crisis and dismal margins are likely to have affected Carter's (CRI) Q2 results. However, solid e-commerce business acts as a cushion to the stock.
WWW or CRI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
WWW vs. CRI: Which Stock Is the Better Value Option?
New Strong Sell Stocks for June 11th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Why Is Carter's (CRI) Up 21.9% Since Last Earnings Report?
by Zacks Equity Research
Carter's (CRI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for May 11th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Carter's (CRI) Stock Down on Q1 Loss, Sales Surpass Estimates
by Zacks Equity Research
Carter's (CRI) Q1 results are affected by store closures, declining sales and soft demand stemming from the COVID-19 crisis. Due to such adverse impacts, management has withdrawn 2020 view.
Earnings Preview: Carter's (CRI) Q1 Earnings Expected to Decline
by Zacks Equity Research
Carter's (CRI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.